This multicenter clinical trial will evaluate the ability of the combination of Indinavir, Zidovudine and Lamivudine to suppress HIV-1 infection as measured by 1) HIV-1 serum viral RNA below the limit of detection, and 2) absence of evidence of infectious virus in lymph node, CSF, PBMCS and semen.
Showing the most recent 10 out of 642 publications